Olema Pharmaceuticals, Inc. (OLMA) Q1 2026 Earnings
OLMA·Reported May 12, 2026·Before market open
Diluted EPS came in at $-0.52 (-44.4% YoY).
Diluted EPS
$-0.52met estimate
Consensus: $-0.52
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Olema Pharmaceuticals, Inc.'s Q1 2026 earnings report.
Olema Pharmaceuticals, Inc. (OLMA) reported Q1 2026 earnings on May 12, 2026 before market open.
Olema Pharmaceuticals, Inc. reported diluted EPS of $-0.52 for Q1 2026.
EPS beat the consensus estimate of $-0.52 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 44.4% from $-0.36.
You can read the 8-K earnings release (0001193125-26-218142) and the 10-Q periodic report (0001193125-26-218156) directly on SEC EDGAR. The filing index links above go to sec.gov.